You are here

  • Home
  • Archive
  • Volume 81, Issue Suppl 1
  • B13 NP03, a low dose lithium microemulsion, improves motor function and rescues striatal pathology without toxicity in the YAC128 mouse model of Huntington's disease

Alerts

Article menu
Download PDFPDF
EHDN Plenary Meeting: abstracts
Experimental therapeutics: preclinical
B13 NP03, a low dose lithium microemulsion, improves motor function and rescues striatal pathology without toxicity in the YAC128 mouse model of Huntington's disease
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address